Morolimumab
Morolimumab is a human monoclonal antibody against the human Rhesus factor.[1][2]
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | RhD |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
(what is this?) (verify) |
References
- "Proposed International Nonproprietary Names: Morolimumab" (PDF). WHO Drug Information. Geneva: World Health Organization. 13 (1): 45. 1991.
- Pelletier JP, Mukhtar F (2020). "Chapter 16 - Passive Monoclonal and Polyclonal Antibody Therapies". In Maitta RW (ed.). Immunologic Concepts in Transfusion Medicine. Philadelphia: Elsevier. p. 300. doi:10.1016/B978-0-323-67509-3.00016-0. ISBN 978-0-323-67510-9.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.